Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012-Reference-Cited by-同舟云学术

Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012

Published:2013-03 Issue:3 Volume:8 Page:373-384
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Hirsch Fred R.,Jänne Pasi A.,Eberhardt Wilfried E.,Cappuzzo Federico,Thatcher Nick,Pirker Robert,Choy Hak,Kim Edward S.,Paz-Ares Luis,Gandara David R.,Wu Yi-Long,Ahn Myung-Ju,Mitsudomi Tetsuya,Shepherd Frances A.,Mok Tony S.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference113 articles.

1. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005

2. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

3. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study;Cappuzzo;Lancet Oncol,2010

4. First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung;Han;J Clin Oncol,2012

5. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial;Mitsudomi;Lancet Oncol,2010

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AE-RW: Predicting miRNA-disease associations by using autoencoder and random walk on miRNA-gene-disease heterogeneous network;Computational Biology and Chemistry;2024-06

2. Improving the identification of miRNA–disease associations with multi-task learning on gene–disease networks;Briefings in Bioinformatics;2023-06-07

3. Interruption of the long non-coding RNA HOTAIR signaling axis ameliorates chemotherapy-induced cachexia in bladder cancer;Journal of Biomedical Science;2022-12-06

4. Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study;Frontiers in Immunology;2021-11-08

5. Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors;BMC Cancer;2021-10-09